Psychiatr Serv 54:665-667, May 2003
© 2003 American Psychiatric Association
Psychopharmacology: Perspectives on Medication Adherence and Atypical Antipsychotic Medications
Dawn I. Velligan, Ph.D.,
Francis Lam, Pharm.D.,
Larry Ereshefsky, Pharm.D. and
Alexander L. Miller, M.D.
Introduction by the column editor: The problem of noncompliance is one that affects all areas of medicine. Some opinion holds that it may be worse for psychiatric disorders, particularly the psychoses, and that the side effects of the older or conventional antipsychotics have played a major role in poor compliance. Side effects have also been proposed as the reason long-acting medications have been unpopular in the United States. This explanation, like many others, seems a bit simplistic and would not explain why European countries and Australia use ten times as many long-acting drugs as the United States.The arrival of atypical antipsychotics, with their lower rate of extrapyramidal effects, was greeted positively as an advance on the older drugs. It was suggested that the lower rate of side effects would improve compliance. However, few data to support this suggestion have been reported.
This article has been cited by other articles:
|
|
|
|
 
J. M. Kane and C. Garcia-Ribera
Clinical guideline recommendations for antipsychotic long-acting injections
The British Journal of Psychiatry,
November 1, 2009;
195(52):
S63 - S67.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Beebe, K. Smith, C. Crye, C. Addonizio, D. J. Strunk, W. Martin, and J. Poche
Telenursing Intervention Increases Psychiatric Medication Adherence in Schizophrenia Outpatients
Journal of the American Psychiatric Nurses Association,
June 1, 2008;
14(3):
217 - 224.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, M. Wang, P. Diamond, D. C. Glahn, D. Castillo, S. Bendle, Y. W. F. Lam, L. Ereshefsky, and A. L. Miller
Relationships Among Subjective and Objective Measures of Adherence to Oral Antipsychotic Medications
Psychiatr Serv,
September 1, 2007;
58(9):
1187 - 1192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Kurtz, E. Baker, G. D. Pearlson, and R. S. Astur
A Virtual Reality Apartment as a Measure of Medication Management Skills in Patients With Schizophrenia: A Pilot Study
Schizophr Bull,
September 1, 2007;
33(5):
1162 - 1170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Singh, A. J. Massey, M. D. Thompson, L. R. Rappa, and M. S. Honeywell
Addressing Nonadherence in the Schizophrenic Population
Journal of Pharmacy Practice,
December 1, 2006;
19(6):
361 - 368.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, Y.-W. F. Lam, D. C. Glahn, J. A. Barrett, N. J. Maples, L. Ereshefsky, and A. L. Miller
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Schizophr Bull,
October 1, 2006;
32(4):
724 - 742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ruddell
Jail Interventions for Inmates With Mental Illnesses
Journal of Correctional Health Care,
April 1, 2006;
12(2):
118 - 131.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. H. Jenkins, M. E. Strauss, E. A. Carpenter, D. Miller, J. Floersch, and M. Sajatovic
Subjective Experience of Recovery from Schizophrenia-Related Disorders and Atypical Antipsychotics
International Journal of Social Psychiatry,
September 1, 2005;
51(3):
211 - 227.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Fayek, C. Flowers, D. Signorelli, and G. Simpson
Psychopharmacology: Underuse of Evidence-Based Treatments in Psychiatry
Psychiatr Serv,
November 1, 2003;
54(11):
1453 - 1456.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Lenroot, J. R. Bustillo, J. Lauriello, and S. J. Keith
Integration of Care: Integrated Treatment of Schizophrenia
Psychiatr Serv,
November 1, 2003;
54(11):
1499 - 1507.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
